©2022 Stanford Medicine
Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
Trial ID: NCT00553826
This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.
Derivation of Primary Donor Cell Lines for Human Cell Reprogramming
Inclusion Criteria:1. Donors with a degenerative disease phenotype or genetic disorders
such as Type I Diabetes, heart disease, or infertility (azoospermia and premature ovarian
Exclusion Criteria:1. Unable to read or understand English. 2. Unable to provide skin
biopsy sample due to skin condition in the underarm area.
procedure: Improving the scientific process of human cell reprogramming